Product Information

CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.6675 per EA under NDC 62559066090. Its NADAC has been published 406 times since Feb 13, 2019.

FDA first approved this application on Sep 5, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB

Candesartan Cilexetil and Hydrochlorothiazide
$0.6675per EA

Strength

16; 12.5 mg/1; mg/1

NDC

62559066090

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Approval Type

Authorized Generic (NDA)

FDA Application

NDA021093

FDA Approved

9/5/2000

TE Code

AB

On Market Since

9/26/2018

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB has been published 406 times since Feb 13, 2019, and over the history we have for it it has declined 77.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6675 per EA
All-time high$3.4335 (Jun 10, 2020)
All-time low$0.6502 (Nov 20, 2024)
52-week high$1.0596
52-week low$0.6675
Median price$1.3820
Average price$1.6204
Largest weekly change+54.4% (Sep 18, 2024)
Weeks tracked406
Tracking sinceFeb 13, 2019

Price History

1W

-14.7%

1M

-30.0%

3M

-31.6%

6M

-37.0%

1Y

-15.1%

3Y

-39.3%

5Y

-65.2%

All

-77.8%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB?

The current National Average Drug Acquisition Cost (NADAC) for CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB, manufactured by ANI Pharmaceuticals, Inc., is $0.6675 per EA (NDC 62559066090), effective Nov 18, 2026.

How has the price of CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB changed over time?

Over the history we have for it, the NADAC for CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB has declined 77.8%. It has been tracked across 406 weekly CMS publications since Feb 13, 2019.

What are the highest and lowest recorded NADAC prices for CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB?

Since Feb 13, 2019, the NADAC for CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB has ranged from a low of $0.6502 (Nov 20, 2024) to a high of $3.4335 (Jun 10, 2020), with a median of $1.3820 per EA.

Are there cheaper alternatives to CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB in a comparable dosage form, but none are currently priced below it.

Who manufactures CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB?

CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB (NDC 62559066090) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.